Lisaftoclax (APG-2575) Is a Novel BCL-2 Inhibitor with Robust Antitumor Activity in Preclinical Models of Hematologic Malignancy
Deng, J; Paulus, A; Fang, DD; Manna, A; Wang, GF; Wang, HB; Zhu, SJ; Chen, JY; Min, P; Yin, Y; Dutta, N; Halder, N; Ciccio, G; Copland, JA; Miller, J; Han, B; Bai, LC; Liu, L; Wang, M; McEachern, D; Przybranowski, S; Yang, CY; Stuckey, JA; Wu, DP; Li, CX; Ryan, J; Letai, A; Ailawadhi, S; Yang, DJ; Wang, SM; Chanan-Khan, A; Zhai, YF
Zhai, YF (通讯作者)，Ascentage Pharm Grp Inc, 700 King Farm Blvd, Suite 510, Rockville, MD 20850 USA.;Chanan-Khan, A (通讯作者)，Mayo Clin, 4500 San Pablo Rd S, Jacksonville, FL 32224 USA.;Wang, SM (通讯作者)，Univ Michigan, Michigan Ctr Therapeut Innovat, Internal Med Pharmacol & Med Chem, 1600 Huron Pkwy NCRC, Bldg 520 Room 1245, Ann Arbor, MI 48109 USA.
CLINICAL CANCER RESEARCH, 2022; 28 (24): 5455
